TY - JOUR
T1 - Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus
T2 - a case report and literature review
AU - Kitamura, Wataru
AU - Kobayashi, Hiroki
AU - Noda, Minori
AU - Iseki, Akiko
AU - Sato, Yumi
AU - Maeda, Yoshinobu
AU - Kuyama, Shoichi
N1 - Publisher Copyright:
© Japanese Society of Hematology 2024.
PY - 2024
Y1 - 2024
N2 - We report a rare case of spontaneous regression (SR) in an elderly untreated patient with multiple solitary plasmacytoma (MSP). Diagnosis of MSP was confirmed through surgical resection of the left nasal cavity mass and subsequent biopsy of the right humerus. The patient was considered ineligible for chemotherapy due to poor performance status. At 3-month post-diagnosis, the patient’s condition worsened with deteriorating bone lesions and emergence of a new serum monoclonal protein. However, these clinical findings completely disappeared at 6 months, and positron emission tomography–computed tomography at 1 year confirmed complete metabolic remission. Notably, peripheral blood lymphocyte counts were inversely correlated with tumor progression and remission. Pathological re-evaluation of the initial biopsy specimens revealed programmed cell death protein 1 (PD-1) expression in tumor-infiltrating CD8+ T cells. In addition, tumor cells were infected with Epstein–Barr virus (EBV) but were negative for programmed cell death ligand 1 (PD-L1) expression, which is the most potent immune escape mechanism in tumor cells. While the mechanism underlying SR remains unclear, our findings suggest that host immune response as well as EBV infection may contribute to SR. Further studies are needed to elucidate the clinicopathologic mechanisms of tumor regression in plasma cell neoplasms.
AB - We report a rare case of spontaneous regression (SR) in an elderly untreated patient with multiple solitary plasmacytoma (MSP). Diagnosis of MSP was confirmed through surgical resection of the left nasal cavity mass and subsequent biopsy of the right humerus. The patient was considered ineligible for chemotherapy due to poor performance status. At 3-month post-diagnosis, the patient’s condition worsened with deteriorating bone lesions and emergence of a new serum monoclonal protein. However, these clinical findings completely disappeared at 6 months, and positron emission tomography–computed tomography at 1 year confirmed complete metabolic remission. Notably, peripheral blood lymphocyte counts were inversely correlated with tumor progression and remission. Pathological re-evaluation of the initial biopsy specimens revealed programmed cell death protein 1 (PD-1) expression in tumor-infiltrating CD8+ T cells. In addition, tumor cells were infected with Epstein–Barr virus (EBV) but were negative for programmed cell death ligand 1 (PD-L1) expression, which is the most potent immune escape mechanism in tumor cells. While the mechanism underlying SR remains unclear, our findings suggest that host immune response as well as EBV infection may contribute to SR. Further studies are needed to elucidate the clinicopathologic mechanisms of tumor regression in plasma cell neoplasms.
KW - Epstein–Barr virus
KW - Plasmacytoma
KW - Spontaneous regression
UR - http://www.scopus.com/inward/record.url?scp=85190370431&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85190370431&partnerID=8YFLogxK
U2 - 10.1007/s12185-024-03765-5
DO - 10.1007/s12185-024-03765-5
M3 - Article
C2 - 38619657
AN - SCOPUS:85190370431
SN - 0925-5710
JO - International journal of hematology
JF - International journal of hematology
ER -